These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 4163610)

  • 1. Occurrence in thyrotoxicosis of a gamma globulin which protects LATS from neutralization by an extract of thyroid gland.
    Adams DD; Kennedy TH
    J Clin Endocrinol Metab; 1967 Feb; 27(2):173-7. PubMed ID: 4163610
    [No Abstract]   [Full Text] [Related]  

  • 2. Failure of long-acting thyroid stimulator globulin (LATS) and serum to stimulate thyroid function in the chick.
    Lepp A; Oliner L
    Endocrinology; 1967 Feb; 80(2):369-74. PubMed ID: 4163488
    [No Abstract]   [Full Text] [Related]  

  • 3. The pathogenesis of thyrotoxicosis the discovery of LATS.
    Adams DD
    N Z Med J; 1975 Jan; 81(531):15-7. PubMed ID: 1055308
    [No Abstract]   [Full Text] [Related]  

  • 4. Stimulation of the human thyroid by infusions of plasma containing LATS protector.
    Adams DD; Fastier FN; Howie JB; Kennedy TH; Kilpatrick JA; Stewart RD
    J Clin Endocrinol Metab; 1974 Nov; 39(5):826-32. PubMed ID: 4425101
    [No Abstract]   [Full Text] [Related]  

  • 5. LATS protector, the human thyroid stimulator.
    Adams DD
    N Z Med J; 1975 Jan; 81(531):22-3. PubMed ID: 1055310
    [No Abstract]   [Full Text] [Related]  

  • 6. The interaction between thyroid tissue and the long-acting thyroid stimulator.
    Kendall-Taylor P; Smith BR; Munro DS
    Q J Med; 1971 Oct; 40(160):564-5. PubMed ID: 4110160
    [No Abstract]   [Full Text] [Related]  

  • 7. REDUCTION OF GAMMA GLOBULIN WITH LONG-ACTING THYROID-STIMULATING ACTIVITY.
    DORRINGTON KJ; MUNRO DS; CARNEIRO L
    Lancet; 1964 Oct; 2(7365):889-91. PubMed ID: 14197190
    [No Abstract]   [Full Text] [Related]  

  • 8. Positive correlation of the long-acting thyroid stimulator (LATS) with the percentage of endogenously labelled 131 I triiodothyronine in the plasma of hyperthyroid patients.
    Emrich D; Albani M; zur Mühlen A von
    Acta Endocrinol (Copenh); 1971 Nov; 68(3):445-50. PubMed ID: 4107957
    [No Abstract]   [Full Text] [Related]  

  • 9. Inhibition of the thyroid-stimulating globulin (LATS) by particulate and soluble cell fractions.
    Benhamou-Glynn N; el-Kabir DJ; Doniach D; Roitt IM
    Proc R Soc Med; 1968 Dec; 61(12):1303-5. PubMed ID: 4178461
    [No Abstract]   [Full Text] [Related]  

  • 10. Relation between thyroid function and serum levels of long-acting thyroid stimulator.
    Davis JC; Hipkin LJ; Summers VK; Gimlette TM
    Acta Endocrinol (Copenh); 1975 Jul; 79(3):451-8. PubMed ID: 1173501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Long-acting thyroid stimulator (LATS) in thyroid gland diseases and its relationship to the thyroid gland antibodies].
    Weissbecker L; Uthgenannt H; Schemmel K; Müller W; Heesen H; Eickenbusch W; Bindeballe W
    Schweiz Med Wochenschr; 1967 Jul; 97(28):898-904. PubMed ID: 5587446
    [No Abstract]   [Full Text] [Related]  

  • 12. Non-specific responses in the assay of thyrotrophin and long-acting thyroid stimulator.
    Adams DD; Kennedy TH; Purves HD
    Aust J Exp Biol Med Sci; 1966 Aug; 44(4):355-64. PubMed ID: 5967342
    [No Abstract]   [Full Text] [Related]  

  • 13. A comparison of the actions of thyroid-stimulating hormone and the long-acting thyroid stimulator in an in vitro assay.
    Brown J; Ensor J; Munro DS
    Proc R Soc Med; 1968 Jul; 61(7):652-4. PubMed ID: 5664277
    [No Abstract]   [Full Text] [Related]  

  • 14. Studies of an in vitro binding reaction between thyroid microsomes and long acting thyroid stimulator globulin (LATS). I. Development of solid-state competitive binding radioassay methods for measurement of antimicrosomal and antithyroglobuin antibodies.
    Mori T; Fisher J; Kriss JP
    J Clin Endocrinol Metab; 1970 Aug; 31(2):119-33. PubMed ID: 4193195
    [No Abstract]   [Full Text] [Related]  

  • 15. A STANDARD FOR THE LONG-ACTING THYROID STIMULATOR (LATS) IN THE SERUM OF PATIENTS WITH THYROTOXICOSIS.
    DORRINGTON KJ; MUNRO DS
    J Endocrinol; 1964 Nov; 31():21-8. PubMed ID: 14231127
    [No Abstract]   [Full Text] [Related]  

  • 16. Induction of a LATS-like response by thyroglobulin in the McKenzie assay system.
    Wood LC; Burger A; Peterson M; Ingbar SH
    Endocrinology; 1973 May; 92(5):1538-43. PubMed ID: 4695433
    [No Abstract]   [Full Text] [Related]  

  • 17. Hyperthyroidism and demonstration of circulating long-acting thyroid stimulator following hypophysectomy for chromophobe adenoma.
    Burke G
    J Clin Endocrinol Metab; 1967 Aug; 27(8):1161-6. PubMed ID: 4166582
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of long-acting thyroid stimulator on thyrotropin stimulation of adenyl cyclase activity in thyroid plasma membranes.
    Yamashita K; Field JB
    J Clin Invest; 1972 Mar; 51(3):463-72. PubMed ID: 4110896
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The value of IgG separation for the detection of LATS in human serum.
    Bonnyns M; Vanhaelst L
    Clin Exp Immunol; 1969 May; 4(5):597-601. PubMed ID: 5815122
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The nature of the interaction between thyroid stimulating gamma G-globulin (long-acting thyroid stimulator) and thyroid tissue.
    Smith BR; Munro DS
    Biochim Biophys Acta; 1970 May; 208(2):285-93. PubMed ID: 5420979
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.